Lyra Therapeutics Ownership | Who Owns Lyra Therapeutics?


OverviewForecastRevenueFinancialsChart

Lyra Therapeutics Ownership Summary


Lyra Therapeutics is owned by 1.99% institutional investors, 0.62% insiders, and 97.39% retail investors. Perceptive advisors is the largest institutional shareholder, holding 17.01% of LYRA shares. iShares Russell 2000 ETF is the top mutual fund, with 3.38% of its assets in Lyra Therapeutics shares.

LYRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLyra Therapeutics1.99%0.62%97.39%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Perceptive advisors229.38K17.01%$1.50M
Sabby management127.62K9.46%$832.87K
Blackrock2.83M4.42%$783.05K
Ikarian capital21.16K1.57%$139.45K
Drw securities16.81K0.95%$51.78K
Goldman sachs group555.51K0.85%$114.66K
Geode capital management12.25K0.69%$37.73K
Caption management246.60K0.39%$68.23K
Susquehanna group, llp103.43K0.16%$21.35K
Blackrock funding, inc. /de2.39K0.14%$7.37K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sabby management127.62K0.96%$832.87K
Perceptive advisors229.38K0.04%$1.50M
Ikarian capital21.16K0.01%$139.45K
Drw securities16.81K0.00%$51.78K
Caption management246.60K0.00%$68.23K
Tower research capital llc (trc)534.000.00%$3.48K
National bank of canada /fi/---
Valley national advisers---
Price t rowe associates inc /md/---
Prelude capital management---

Top Buyers

HolderShares% AssetsChange
Blackrock2.83M-2.68M
Caption management246.60K0.00%246.60K
Susquehanna group, llp103.43K-90.52K
Drw securities16.81K0.00%16.81K
Goldman sachs group555.51K-8.17K

Top Sellers

HolderShares% AssetsChange
Nantahala capital management---2.82M
Point72 asset management---2.74M
Vr adviser---2.58M
Pura vida investments---1.41M
Samsara biocapital---1.39M

New Positions

HolderShares% AssetsChangeValue
Caption management246.60K0.00%246.60K$68.23K
Drw securities16.81K0.00%16.81K$51.78K
Advisor group22.00-22.00$143.00
Global retirement partners15.00-15.00$46.00

Sold Out

HolderChange
Raymond james financial-8.00
Nisa investment advisors-10.00
Principal securities-19.00
Farther finance advisors-38.00
Wells fargo & company/mn-39.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202516-36.00%35,150-92.16%10.18%5-44.44%5-54.55%
Sep 30, 202524-14.29%448,586-8.79%332.50%9-10.00%10-44.44%
Jun 30, 202529-49.12%493,995-98.07%362.54%10-50.00%19-
Mar 31, 20255-90.74%15,783,037-41.30%241.42%1-96.43%1-91.67%
Dec 31, 202454-12.90%26,885,924-17.35%411.66%28-12.50%12-14.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF44.78K3.38%-
Vanguard US Total Market Shares ETF992.54K1.51%2.00
Vanguard Total Stock Mkt Idx Inv19.43K1.20%-424.00
iShares Russell 2000 Growth ETF408.38K0.62%-
Fidelity Small Cap Index6.33K0.40%-
Fidelity Extended Market Index6.60K0.37%1.26K
Vanguard Institutional Extnd Mkt Idx Tr6.26K0.35%-
Vanguard Russell 2000 ETF4.83K0.30%24.00
Russell 3000 Screened Index Composite186.70K0.29%186.70K
Spartan Total Market Index Pool E140.13K0.21%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 06, 2026Cavalier Jason Chief Financial OfficerSell$2.59K
Jan 06, 2026Palasis Maria President & CEOSell$5.73K
Nov 11, 2025PERCEPTIVE ADVISORS LLC-Sell$2.32K
Nov 12, 2025PERCEPTIVE ADVISORS LLC-Sell$31.91K
Nov 11, 2025PERCEPTIVE ADVISORS LLC-Sell$20.64K

Insider Transactions Trends


DateBuySell
2026 Q1-2
2025 Q4-12
2025 Q3-2
2025 Q2--
2025 Q1--

LYRA Ownership FAQ


Who Owns Lyra Therapeutics?

Lyra Therapeutics shareholders are primarily institutional investors at 1.99%, followed by 0.62% insiders and 97.39% retail investors. The average institutional ownership in Lyra Therapeutics's industry, Biotech Stocks , is 381.47%, which Lyra Therapeutics falls below.

Who owns the most shares of Lyra Therapeutics?

Lyra Therapeutics’s largest shareholders are Perceptive advisors (229.38K shares, 17.01%), Sabby management (127.62K shares, 9.46%), and Blackrock (2.83M shares, 4.42%). Together, they hold 30.89% of Lyra Therapeutics’s total shares outstanding.

Does Blackrock own Lyra Therapeutics?

Yes, BlackRock owns 4.42% of Lyra Therapeutics, totaling 2.83M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 783.06K$. In the last quarter, BlackRock increased its holdings by 2.68M shares, a 1762.82% change.

Who is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Sabby management is Lyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.96% of its assets in 127.62K Lyra Therapeutics shares, valued at 832.87K$.

Who is the top mutual fund holder of Lyra Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Lyra Therapeutics shares, with 3.38% of its total shares outstanding invested in 44.78K Lyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools